USPTO 2015–2025 USPTO PatentsView US Corporation

Novarad Corporation

USPTO PatentsView assignee record - 22 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06T (Image Data Processing OR Generation, IN General).

RSS updates for this company

The verdict

According to USPTO PatentsView, Novarad ranks #13,585 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 9 technology areas.

#13,585
of 49,997 US assignees by volume
Top 17%
by Innovation Score (48.4/100)
22.7
avg claims per patent
+86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13585 · US Corporation #13,585 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 22 grants
  • MID-PACK #13,585/49,997
  • PHOTO-FINISH New York Stem Cell…
  • CPC-NARROW G06T · 9 areas
  • INNOV-PAR 48.4/100
  • CLAIMS-DENSE 22.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: New York Stem Cell Foundation, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novarad’s 48.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Novarad

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Novarad's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Novarad?

Each dot is one of Novarad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novarad’s own 22.7 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Novarad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 21.921.92222.1 0510152025 Granted patents (volume) Avg claims / patent New York Stem Cell Foundation, Inc. - 22, 17.82New York Stem Cel…Nexenta Systems, Inc. - 22, 16.45Nexenta SystemsNext Science IP Holdings Pty Ltd - 22, 16.23Next Science IP H…Ningbo Albert Novosino Co., Ltd. - 22, 4.27Ningbo Albert Nov…NuSirt Sciences, Inc. - 22, 22.91Nusirt SciencesOE Solutions America, Inc. - 22, 15.73OE Solutions Amer…OHC IP Holdings, LLC - 22, 15.14OHC IP HoldingsOIL States Industries, Inc. - 22, 19.68OIL States Indust…Novarad Corporation - 22, 22.68Novarad
Novarad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novarad's grants concentrate

Novarad Corporation is a focused PatentsView assignee: 9 CPC subclasses with 81.8% of grants classified under G06T (Image Data Processing OR Generation, IN General). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2017. By volume, Novarad sits between New York Stem Cell Foundation, Inc. and OIL States Industries, Inc..

Novarad's three-year grant acceleration

Novarad Corporation shows 10 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Novarad's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Novarad holds 22 patents at rank #13,584, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Novarad

By rank, the assignees closest to #13,584 in granted patent volume.

Leaders in G06T (Image Data Processing OR Generation)

Other assignees with the most granted patents in Novarad's primary technology class.

Novarad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20172018201920202021202220242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Novarad Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 4.5%
2018 4 18.2%
2019 2 9.1%
2020 1 4.5%
2021 2 9.1%
2022 4 18.2%
2024 6 27.3%
2025partial year 2 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Novarad Corporation's patent record in context - here's where to go next.

  • Novarad Corporation's lead technology class is G06T (Image Data Processing OR Generation, IN General), 81.8% of its portfolio - see every assignee active in that class. Explore G06T
  • Ranked #13,585 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Novarad Corporation against New York Stem Cell Foundation, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.